Most Recent
A Federal Court judge has admonished Federal Circuit Court Judge Sandy Street for “a complete lack of intellectual engagement” in considering whether an Indian migrant engaged in a sham marriage in order to stay in Australia.
Cladding manufacturer Fairview Architectural may have $190 million in insurance to cover the claims in a class action over its allegedly combustible cladding products.
Six of the world's largest car makers have agreed to settle class actions accusing them of selling cars with deadly Takata airbags.
The state of Victoria has opted out of two class actions over allegedly combustible cladding, after agreeing to join as a group member last year.
A class action has been filed on behalf of major retailers seeking compensation over a May 2020 incident on the MV APL England vessel which saw valuable goods en route to Australia damaged or lost overboard during rough weather.
The lead plaintiff in a class action against security firms Unified and MSS Security over last year's second COVID-19 wave in Victoria might drag an insurer into the proceedings after Unified went into liquidation.
The ACCC has suffered a stinging defeat in its criminal cartel action against mobility equipment provider Country Care, its CEO and a former employee, with a jury handing down not guilty verdicts on all eight charges in the case.
Chinese lender Aoyin wants to join Baker McKenzie to its claims against PwC over a failed bid to launch the first Chinese bank incorporated in Australia, after advice documents from the law firm were uncovered in a last-minute privilege fight.
The lead applicant in a class action against Bayer over its allegedly defective Essure contraceptive devices has won court approval to drop her consumer law claims against the German drug maker, with a judge agreeing that the plaintiff's defect and negligence claims had a better chance of succeeding.
Lawyers welcomed the government's "overdue" announcement of a so-called patent box that will slash the tax rate on income derived from patented drug and biotech inventions developed in Australia, but called on the government to apply the regime to other sectors.